Results
|
|
1561.
|
|
|
|
1562.
|
|
|
|
1563.
|
Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4 [electronic resource] by
- Mastracci, Luca
- Fontana, Vincenzo
- Queirolo, Paola
- Carosio, Roberta
- Grillo, Federica
- Morabito, Anna
- Banelli, Barbara
- Tanda, Enrica
- Boutros, Andrea
- Dozin, Beatrice
- Gualco, Marina
- Salvi, Sandra
- Romani, Massimo
- Spagnolo, Francesco
- Poggi, Alessandro
- Pistillo, Maria Pia
Producer: 20200420
In:
Cancer immunology, immunotherapy : CII vol. 69
Availability: No items available.
|
|
|
1564.
|
|
|
|
1565.
|
A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma. [electronic resource] by
- Weber, Jeffrey
- Thompson, John A
- Hamid, Omid
- Minor, David
- Amin, Asim
- Ron, Ilan
- Ridolfi, Ruggero
- Assi, Hazem
- Maraveyas, Anthony
- Berman, David
- Siegel, Jonathan
- O'Day, Steven J
Producer: 20091211
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 15
Availability: No items available.
|
|
|
1566.
|
|
|
|
1567.
|
|
|
|
1568.
|
Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial. [electronic resource] by
- Hodi, F Stephen
- Lee, Sandra
- McDermott, David F
- Rao, Uma N
- Butterfield, Lisa H
- Tarhini, Ahmad A
- Leming, Philip
- Puzanov, Igor
- Shin, Donghoon
- Kirkwood, John M
Producer: 20141124
In:
JAMA vol. 312
Availability: No items available.
|
|
|
1569.
|
|
|
|
1570.
|
Ipilimumab for advanced melanoma: experience from the Spanish Expanded Access Program. [electronic resource] by
- Berrocal, Alfonso
- Arance, Ana
- Lopez Martin, Jose Antonio
- Soriano, Virtudes
- Muñoz, Eva
- Alonso, Lorenzo
- Espinosa, Enrique
- Lopez Criado, Pilar
- Valdivia, Javier
- Martin Algarra, Salvador
Producer: 20150811
In:
Melanoma research vol. 24
Availability: No items available.
|
|
|
1571.
|
|
|
|
1572.
|
|
|
|
1573.
|
|
|
|
1574.
|
|
|
|
1575.
|
|
|
|
1576.
|
Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer. [electronic resource] by
- Hellmann, Matthew D
- Callahan, Margaret K
- Awad, Mark M
- Calvo, Emiliano
- Ascierto, Paolo A
- Atmaca, Akin
- Rizvi, Naiyer A
- Hirsch, Fred R
- Selvaggi, Giovanni
- Szustakowski, Joseph D
- Sasson, Ariella
- Golhar, Ryan
- Vitazka, Patrik
- Chang, Han
- Geese, William J
- Antonia, Scott J
Producer: 20190227
In:
Cancer cell vol. 33
Availability: No items available.
|
|
|
1577.
|
|
|
|
1578.
|
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC). [electronic resource] by
- Cottrell, T R
- Thompson, E D
- Forde, P M
- Stein, J E
- Duffield, A S
- Anagnostou, V
- Rekhtman, N
- Anders, R A
- Cuda, J D
- Illei, P B
- Gabrielson, E
- Askin, F B
- Niknafs, N
- Smith, K N
- Velez, M J
- Sauter, J L
- Isbell, J M
- Jones, D R
- Battafarano, R J
- Yang, S C
- Danilova, L
- Wolchok, J D
- Topalian, S L
- Velculescu, V E
- Pardoll, D M
- Brahmer, J R
- Hellmann, M D
- Chaft, J E
- Cimino-Mathews, A
- Taube, J M
Producer: 20191223
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 29
Availability: No items available.
|
|
|
1579.
|
Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapy. [electronic resource] by
- Goswami, Sangeeta
- Apostolou, Irina
- Zhang, Jan
- Skepner, Jill
- Anandhan, Swetha
- Zhang, Xuejun
- Xiong, Liangwen
- Trojer, Patrick
- Aparicio, Ana
- Subudhi, Sumit K
- Allison, James P
- Zhao, Hao
- Sharma, Padmanee
Producer: 20190924
In:
The Journal of clinical investigation vol. 128
Availability: No items available.
|
|
|
1580.
|
|